ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1933

Small Vessel Vasculitis Surrounding a Preserved Temporal Artery: Search for Tissue Biomarkers with Potential Diagnostic Value

Georgina Espígol-Frigolé1, Roser Alba-Rovira2, Salvador Naranjo-Suárez3, Magda Terenas4, Sergio Prieto-González1, Marc Corbera-Bellalta3, Javier Marco-Hernández4, Marco A. Alba1, Farah Kamberovic3, Roberto Ríos-Garcés1, Jose Hernández-Rodríguez1 and Maria C. Cid1, 1Vasculitis Research Unit, Department of Systemic Autoimmune Diseases, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Barcelona, Catalonia, Spain, 2Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, IRB-CELLEX. Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, 3IDIBAPS, Barcelona, Spain, 4Hospital Clinic Barcelona, Barcelona, Spain

Meeting: ACR Convergence 2020

Keywords: Biomarkers, Gene Expression, genomics, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic vasculitides are complex and heterogeneous diseases with overlapping features that frequently pose a diagnostic challenge to clinicians. The temporal artery biopsy (TAB) is the gold standard for the diagnosis of giant cell arteritis (GCA) with cranial involvement. Occasionally, the TAB shows small vessel vasculitis (SVV) surrounding a normal temporal artery as the only pathological finding. Ultimate diagnosis and, consequently, optimal treatment remain uncertain in these patients.

The aim of this project is to characterize biomarkers with diagnostic potential in TAB disclosing SVV surrounding a spared temporal artery. 

Methods: 51 Patients with TAB showing SVV surrounding a normal temporal artery were subjected to a pre-established diagnostic algorithm combining clinical, imaging and serological data (Fig 1). The algorithm led to the following classification: 19 GCA; 20 systemic vasculitis (ANCA-associated vasculitis (AAV) and other vasculitis); and 12 could not be classified. TAB samples from 15 SVV patients (8 classified as GCA[SVV-GCA] and 7 systemic vasculitis [SVV-SV]: 4 AAV and 3 other vasculitis) and 16 controls with negative temporal artery biopsies, were used for RNA isolation and microarray hybridization (Human Clariom S, Affymetrix).  Genes differentially expressed were identified by a multivariate permutation t test using the BRB ArrayTools 4.6 software package (Biometric Research Branch, NCI). We set parameters in the univariate 2-sample t test permutation with a random variance model. Permutation P values for significant genes (P < 0.001) were computed based on 10,000 random permutations that result in an estimated false discovery rate below 1%.

Results: We compared gene expression in normal temporal arteries and the different subgroups of SVV. The expression level of 42 genes was found to be significantly different between normal arteries and SVV-GCA, whereas the expression level of 65 genes was significantly different between normal arteries and SVV-SV. Interestingly, an unsupervised hierarchical clustering based on this subset of 107 genes was able to cluster subgroups of SVV: SVV-GCA and SVV-SV (Fig 2). In addition, a hierarchical clustering analysis yielded a subset of 8 genes with significant different expression between SVV-GCA and SVV-SV (Fig 3). Sub-analysis between SVV-GCA and SVV-AAV and SVV-GCA and SVV-other vasculitis, showed significant differences in expression level of 17 and 23 genes respectively.

Conclusion: SVV surrounding a spared TA is a relevant but equivocal finding. After a detailed diagnostic work-up most patients can be diagnosed with GCA or other systemic vasculitis although diagnosis remains uncertain in some cases. Cluster analysis of the gene expression profile differentiates diagnostic subgroups of SVV. Further studies are needed to validate differentially expressed genes.

“Supported by PI15/00092, Plan Estatal de Investigación Científica y Técnica de Innovación 2013-2016 y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER)”


Disclosure: G. Espígol-Frigolé, None; R. Alba-Rovira, None; S. Naranjo-Suárez, None; M. Terenas, None; S. Prieto-González, None; M. Corbera-Bellalta, None; J. Marco-Hernández, None; M. Alba, None; F. Kamberovic, None; R. Ríos-Garcés, None; J. Hernández-Rodríguez, None; M. Cid, Kiniksa, 2.

To cite this abstract in AMA style:

Espígol-Frigolé G, Alba-Rovira R, Naranjo-Suárez S, Terenas M, Prieto-González S, Corbera-Bellalta M, Marco-Hernández J, Alba M, Kamberovic F, Ríos-Garcés R, Hernández-Rodríguez J, Cid M. Small Vessel Vasculitis Surrounding a Preserved Temporal Artery: Search for Tissue Biomarkers with Potential Diagnostic Value [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/small-vessel-vasculitis-surrounding-a-preserved-temporal-artery-search-for-tissue-biomarkers-with-potential-diagnostic-value/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/small-vessel-vasculitis-surrounding-a-preserved-temporal-artery-search-for-tissue-biomarkers-with-potential-diagnostic-value/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology